Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia

Novartis International AG / Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

• One million antimalarial treatments donated by Novartis, matching one million treatments funded through Malaria No More's Power of One campaign

• Power of One enables the public to fund malaria tests and treatments for children in Africa through online and mobile technology

• Today marks World Health Day, focusing on vector-borne diseases, of which malaria is the most deadly[1]

Basel, Switzerland, April 7, 2014 - Novartis announced today that two million treatments of its pediatric antimalarial are arriving in Zambia thanks to the ongoing efforts of the company in collaboration with Malaria No More's Power of One campaign. Zambia is the first beneficiary country of this campaign sponsored by Novartis. One million treatments of Coartem^® Dispersible have been funded through public donations and Novartis matched these with a further one million treatments. These antimalarials will reduce the disease burden in Zambia, which accounts for up to 40% of infant mortality in that country[2].

"Although the incidence of malaria has decreased, the disease still kills a child every minute in Africa," said Joseph Jimenez, CEO of Novartis. "Our commitment to Power of One reflects our company's long-term efforts to fight malaria and Novartis remains dedicated to controlling and ultimately eliminating this deadly disease."

Power of One is a global digital fundraising campaign that enables people around the world to help end child deaths from malaria, a preventable and treatable disease. This fatal disease has been recognized by the World Health Organization as a priority area of public health. This year's World Health Day focuses on vector-borne diseases, and malaria is the most deadly[1].

The campaign, which launched to the public in September 2013, uses social, mobile, and e-commerce technologies, enabling the public to purchase treatments for children in Zambia. Donors are able to share information with their social networks and encourage friends to donate.

"One and a half million treatments are already on the ground in Zambia thanks to the Power of One campaign, with a further 500,000 anticipated in the coming weeks," said Martin Edlund, CEO, Malaria No More. "Power of One is resonating with the general public, and their donations will help us ensure that children in Zambia will have access to the treatment they need."